Urodynamic studies and features of anaesthesia during intradetrusor botulinum therapy in the context of the COVID-19 pandemic (literature review)

Cover Page

Cite item

Full Text

Abstract

The coronavirus pandemic has had a severe impact on the health care system. It is also changing the appointment and conduct of diagnostic procedures, emergency and routine medical care. 

According to the medical guidelines of the European Society of Urology (EAU) for the provision of urological care during the current epidemic situation, various levels of urgency have been proposed for diagnostic and therapeutic measures depending on the type of disease. Urodynamic studies refer to studies with a priority level from P2 (for neurogenic dysfunction of the urinary tract) to P4 (for lower urinary tract dysfunction without the risk of damage to the upper urinary tract). The question arises regarding the safety of these studies, both for patients and medical staff, and possible measures to reduce the risk of infection in a viral pandemic. 

Because of the increased workload of hospitals that have not been redesigned for the fight against coronavirus infection and provide routine and emergency urological care, an even greater need has arisen to find effective and safe methods of local anaesthesia for performing urodynamic studies and intradetrusive injections of botulinum toxin type A under local anesthesia in outpatient and outpatient settings (for example, in a short-term hospital). 

This article presents a literature review on the principles and features of performing urodynamic studies in the context of the Covid-19 pandemic and the effectiveness and safety of using various methods of local anaesthesia when performing intradetrusor injections of botulinum toxin with detrusor hyperactivity of a neurogenic and non-neurogenic nature. There were evaluated forms of local anaesthesia such as intradetrusor instillation of lidocaine, electrophoresis, and the use of alternative solutions for urinary bladder irrigation (for example, Ringer’s solution).

About the authors

Dmitriy A. Lysachev

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Author for correspondence.
Email: noemail@neicon.ru
ORCID iD: 0000-0002-9872-0959
Russian Federation

Lyubov A. Khodyreva

Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department

Email: khodyreva60@mail.ru
ORCID iD: 0000-0002-0751-4982

Doctor Med. Sci., PhD, Professor, Head of the Urology department Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department, Moscow, 115184, Russian Federation.

e-mail: khodyreva60@mail.ru

Russian Federation

Roman V. Stroganov

Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department; Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Email: noemail@neicon.ru
ORCID iD: 0000-0002-5529-1787
Russian Federation

Yuri A. Kupriyanov

Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department; Moscow State University of Medicine and Dentistry named after A.I. Evdokimov

Email: noemail@neicon.ru
ORCID iD: 0000-0002-5807-7591
Russian Federation

References

  1. Shabunin A.V., Pushkar’ D.Yu., Kasyan G.R., Vasil’ev A.O. Emergency surgical care in the conditions of COVID-19. Practical recommendations. Moscow; 2020. (in Russian)
  2. Pushkar’ D.Yu., Pogonin A.V., Kuandykova M.V., Kasyan G.R., Govorov A.V., Kolontarev K.B., et al. Temporary guidelines for the provision of specialized medical care to the adult population in the «Urology» profile in the context of a new coronavirus infection COVID-19. Methodological recommendations No. 39. Practical recommendations. Moscow; 2020. (in Russian)
  3. Lee S., Gammie A., Bevan W., Chew C., Hassine A., Abrams P. Assessment of quality control in urodynamics: cough vs valsalva. Neurourol. Urodyn. 2021; 40(4): 1021-6. https://doi.org/10.1002/nau.24661
  4. Hashim H., Tomas L., Gammie A., Frarullo G., Finazzi-Agrò E. Good urodynamic practice adaptations during the COVID-19 pandemia. Neurourol. Urodyn. 2020; 39(6): 1897-901. https://doi.org/10.1002/nau.24441
  5. Corcos J., Przydacz M. Consultation in Neurourology. Springer; 2018. https://doi.org/10.1007/978-3-319-63910-9
  6. Teoh J.Y., Ong W., Gonzalez-Padilla D., Castellani D., Dubin J.M., Esperto F., et al. A global survey on the impact of COVID-19 on Urological Services. Eur. Urol. 2020; 78(2): 265-75. https://doi.org/10.1016/j.eururo2020.05.025
  7. Musco S., Del-Popolo G., Lamartina M., Herms A., Renard J., Manassero A., et al. Neuro-Urology during the Covid-19 pandemic: triage and priority of treatments. Neurourol. Urodyn. 2020; 39(7): 2011-5. https://doi.org/10.1002/nau.24460
  8. Clinic guide to surgical prioritization during the coronavirus pandemic. Available at: https://www.england.nhs.uk/coronavirus/wpcontent/uploads/sites/52/2020/03/CO221-speacelty-guide-surgical-prioritisation-v1.pdf
  9. Ghezzi A., Carone R., Del Popolo G., Amato M.P., Bertolotto A., Comola M., et al. Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group. Neurol. Sci. 2011; 32(6): 1223-31. https://doi.org/10.1007/s10072-011-0794-y
  10. Finazzi Agrò E., Farullo G., Balzarro M., Del Popolo G., Giannantoni A., Herms A., et al. Triage of functional, female and neuro-urology patients during and immediately after the Covid-19 outbreak. Minerva Urol. Nefrol. 2020; 72(4): 513-5. https://doi.org/10.23736/S0393-2249.20.03909-0
  11. Rapid Reaction Recommendations: EAU COVID-19. Available at: https://uroweb.org/guideline/covid-19-recommendations/
  12. Huri E., Hamid R. Technology-based management of neurourology patients in the COVID-19 pandemic: Is this the future? A report from the International Continence Society (ICS) institute. Neurourol. Urodyn. 2020; 39(6): 1885-8. https://doi.org/10.1002/nau.24429
  13. Stephen R.L., Miotti D., Bettaglio R., Rossi C., Bonezzi C. Electromotive administration of a new morphine formulation: morphine citrate. Artif. Organs. 1994; 18(6): 461-5. https://doi.org/10.1111/j.1525-1594.1994.tb02233.x
  14. Cohen B.L., Rivera R., Barboglio P., Gousse A. Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection. J. Urol. 2007; 177(3): 1006-10. https://doi.org/10.1016/j.juro.2006.10.050
  15. Nambiar A.K., Younis A., Khan Z.A., Hildrup I., Emery S.J., Lucas M.G. Alkalinized lidocaine versus lidocaine gel as local anesthesia prior to intra-vesical botulinum toxin (BoNTA) injections: A prospective, single center, randomized, double-blind, parallel group trial of efficacy and morbidity. Neurourol. Urodyn. 2016; 35(4): 522-7. https://doi.org/10.1002/nau.22750
  16. Narahashi T., Frazier T., Yamada M. The site of action and active form of local anesthetics. I. Theory and PH experiments with tertiary compounds. J. Pharmacol. Exp. Ther. 1970; 171(1): 32-44.
  17. Tucker G.M., Mather L.E. Chapter 3: Properties, absorption and disposition of local anesthetic agents. In: Cousins M.J., ed. Neural Blockade in Clinical Anesthesia and Management of Pain. Philiadelphia: Lippincott-Raven; 1998: 55-86.
  18. LeClaire E.L., Duong J., Wykes R.M., Miller K.E., Winterton T.L., Bimali M. Randomized controlled trial of belladonna and opiate suppository during intravesical onabotulinum toxin A injection. Am. J. Obstet. Gynecol. 2018; 219(5): 488.e1-7. https://doi.org/10.1016/j.ajog.2018.06.004
  19. Schurch B., Reitz A., Tenti G. Electromotive drug administration of lidocaine to anesthetize the bladder before botulinum - A toxin injections into the detrusor. Spinal Cord. 2004; 42(6): 338-41. https://doi.org/10.1038/sj.sc.3101593
  20. Gangarosa L.P., Park N.H., Wiggins C.A., Hill J.M. Increased penetration of nonelectrolytes into mouse skin during iontophoretic water transport (iontohydrokinesis). J. Pharmacol. Exp. Ter. 1980; 212(3): 377-81.
  21. Fontanella U.A., Rossi C.A., Stephen R.L. Bladder and urethral anaesthesia with electromotive drug administration (EMDA): a technique for invasive endoscopic procedures. Br. J. Urol. 1997; 79(3): 414-20. https://doi.org/10.1046/j.1464-410X.1997.32419.x
  22. Chandiramani V.A., Peterson T., Duthie G.S., Fowler C.J. Urodynamic changes during therapeutic intravesical instillations of capsaicin. Br. J. Urol. 1996; 77(6): 792-7. https://doi.org/10.1046/j.1464-410x.1996.09844.x
  23. Gürpinar T., Wong H.Y., Griffith D.P. Electromotive administration of intravesical lidocaine in patients with interstitial cystitis. J. Endourol. 1996; 10(5): 443-7. https://doi.org/10.1089/end.1996.10.443

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Lysachev D.A., Khodyreva L.A., Stroganov R.V., Kupriyanov Y.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ:  ПИ № ФС77-50668 от 13.07.2012 г.